Search Results - "TOSHIHIRO TAJIMA"
-
1
Genetic causes of central precocious puberty
Published in Clinical Pediatric Endocrinology (01-07-2022)“…[Highlights] ●The review clarifies new genetic etiologies of CPP. ●The genetic etiologies are useful for a better understanding of the timing of puberty. ●The…”
Get full text
Journal Article -
2
Newborn Screening in Japan-2021
Published in International journal of neonatal screening (04-01-2022)“…Japan's Newborn Mass Screening (NBS) was started in 1977 for amino acid metabolism disorders (phenylketonuria (PKU), homocystinuria, maple syrup urine,…”
Get full text
Journal Article -
3
Genetic causes of central precocious puberty
Published in Clinical Pediatric Endocrinology (01-01-2022)“…Central precocious puberty (CPP) is a condition in which the hypothalamus–pituitary–gonadal system is activated earlier than the normal developmental stage…”
Get full text
Journal Article -
4
Health problems of adolescent and adult patients with 21-hydroxylase deficiency
Published in Clinical Pediatric Endocrinology (01-01-2018)“…Twenty-one-hydroxylase deficiency (21-OHD) is one of the most common forms of congenital adrenal hyperplasias. Since the disease requires life-long steroid…”
Get full text
Journal Article -
5
Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion]
Published in ENDOCRINE JOURNAL (01-01-2016)“…This clinical practice guideline of the diagnosis and treatment of adrenal insufficiency (AI) including adrenal crisis was produced on behalf of the Japan…”
Get full text
Journal Article -
6
Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan
Published in ENDOCRINE JOURNAL (01-01-2020)“…Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis that causes various symptoms such as skeletal malformations, disorders of sex…”
Get full text
Journal Article -
7
Current status of transition medicine for 21-hydroxylase deficiency in Japan: from the perspective of pediatric endocrinologists
Published in ENDOCRINE JOURNAL (01-01-2022)“…To manage of 21-hydroxylase deficiency (21-OHD), transition medicine from pediatric to adult health care is an important process and requires individually…”
Get full text
Journal Article -
8
-
9
A novel nonsense variant (p.Arg1293Ter) of the immunoglobulin superfamily 1 (IGSF1) associated with congenital hypogonadotropic hypogonadism and central hypothyroidism
Published in Clinical Pediatric Endocrinology (01-04-2022)“…[Introduction] Individuals with deletions and/or pathogenic variants of the Immunoglobulin superfamily 1 (IGSF1) gene may show congenital central…”
Get full text
Journal Article -
10
Health problems of adolescent and adult patients with 21-hydroxylase deficiency
Published in Clinical Pediatric Endocrinology (01-10-2018)“…[Abstract.] Twenty-one-hydroxylase deficiency (21-OHD) is one of the most common forms of congenital adrenal hyperplasias. Since the disease requires life-long…”
Get full text
Journal Article -
11
Treatment of X-Linked Hypophosphatemia in Children
Published in Endocrines (11-08-2022)“…The conventional treatment for X-linked hypophosphatemia (XLH), consisting of phosphorus supplementation and a biologically active form of vitamin D…”
Get full text
Journal Article -
12
Acute Perimyocarditis in an Adolescent Japanese Male after a Booster Dose of the BNT162b2 COVID-19 Vaccine
Published in The Tohoku Journal of Experimental Medicine (2022)“…Perimyocarditis is a rare and serious cardiac complication following COVID-19 vaccination. Young males are most at risk after the second dose. With the…”
Get full text
Journal Article -
13
Clinical features and molecular basis of pseudohypoaldosteronism type 1
Published in Clinical Pediatric Endocrinology (01-01-2017)“…Pseudohypoaldosteronism (PHA) type 1 is a disease showing mineralocorticoid resistance in the kidney and/or other mineralocorticoid target tissues. Patients…”
Get full text
Journal Article -
14
Neonatal mass screening for 21-hydroxylase deficiency
Published in Clinical Pediatric Endocrinology (01-01-2016)“…Congenital adrenal hyperplasia(CAH)due to 21-hydroxylase deficiency (21-OHD) is an inherited autosomal recessive disorder. Its incidence is 1 in 10,000 to…”
Get full text
Journal Article -
15
Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)
Published in Clinical Pediatric Endocrinology (2023)“…Purpose of developing the guidelines: Newborn screening (NBS) for congenital hypothyroidism (CH) was started in 1979 in Japan, and early diagnosis and…”
Get full text
Journal Article -
16
A novel mutation of IGSF1 in a Japanese patient of congenital central hypothyroidism without macroorchidism [Rapid Communication]
Published in ENDOCRINE JOURNAL (2013)“…Congenital central hypothyroidism (C-CH) is a rare disease known to be caused by mutations of the genes encoding TSH β or the TRH receptor gene, although the…”
Get full text
Journal Article -
17
The progression of salt‐wasting and the body weight change during the first 2 weeks of life in classical 21‐hydroxylase deficiency patients
Published in Clinical endocrinology (Oxford) (01-02-2021)“…Background One of the major purposes of newborn screening for 21‐hydroxylase deficiency (21OHD) is preventing life‐threatening adrenal crisis. However, the…”
Get full text
Journal Article -
18
Recent advances in research on isolated congenital central hypothyroidism
Published in Clinical Pediatric Endocrinology (01-01-2019)“…Congenital central hypothyroidism (C-CH) is caused by defects in the secretion of thyrotropin-releasing hormone (TRH) and/or TSH, leading to an impairment in…”
Get full text
Journal Article -
19
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Published in Clinical Pediatric Endocrinology (01-01-2022)“…Congenital adrenal hyperplasia is a category of disorders characterized by impaired adrenocortical steroidogenesis. The most frequent disorder of congenital…”
Get full text
Journal Article -
20
Functional analysis of PAX8 variants identified in patients with congenital hypothyroidism in situ
Published in Clinical Pediatric Endocrinology (2022)“…Paired box transcription factor 8 (PAX8) is essential for thyroid organogenesis and development. Heterozygous pathogenic variants of PAX8 typically cause…”
Get full text
Journal Article